Literature DB >> 6927751

Antioxidants in pharmaceutical products.

M J Akers.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6927751

Source DB:  PubMed          Journal:  J Parenter Sci Technol        ISSN： 0279-7976


× No keyword cloud information.
  6 in total

Review 1.  Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.

Authors:  Yongmei Wu; Jaquan Levons; Ajit S Narang; Krishnaswamy Raghavan; Venkatramana M Rao
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

2.  Stabilization of lyophilized porcine pancreatic elastase.

Authors:  B S Chang; C S Randall; Y S Lee
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

Review 3.  Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Authors:  Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker
Journal:  AAPS J       Date:  2014-11-15       Impact factor: 4.009

4.  Polymeric systems for amorphous Delta9-tetrahydrocannabinol produced by a hot-melt method. Part II: Effect of oxidation mechanisms and chemical interactions on stability.

Authors:  Manish Munjal; Mahmoud A Elsohly; Michael A Repka
Journal:  J Pharm Sci       Date:  2006-11       Impact factor: 3.534

5.  Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine.

Authors:  Michelle Z Dion; Danielle Leiske; Vikas K Sharma; Christina L Zuch de Zafra; Cleo M Salisbury
Journal:  Pharm Res       Date:  2018-10-02       Impact factor: 4.200

Review 6.  Oxidation of Drugs during Drug Product Development: Problems and Solutions.

Authors:  Alen Gabrič; Žiga Hodnik; Stane Pajk
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.